Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × Topotecan × Clear all

NCT01039025 2018-11-07

TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma

Phase 2 Completed

Neoplasms, Plasma Cell